Literature DB >> 30911235

Adaptation of the Cognitive Triad Inventory into Turkish: a Validity and Reliability Study.

Özge Erarslan1, Sedat Işikli2.   

Abstract

INTRODUCTION: The aim of this study was to assess psychometric properties of the Turkish version of The Cognitive Triad Inventory developed to use cognitive triad based on Beck's depression model.
METHODS: The study sample included 337 (female 72.2%, male 27.8%) students from Hacettepe University. Reliability was evaluated by test-retest analysis and internal consistency coefficients. For validity, explanatory and confirmatory factor analyses were performed. In addition, the scales which are assumed to measure similar cognitive structures were used to examine convergent validity. The Cognitive Triad Inventory, Beck Depression Inventory and The Hopelessness Scale were administered to the participants.
RESULTS: The Cronbach Alpha coefficient reliability of The Cognitive Triad Inventory (r=0.91) showed that internal consistency reliability of inventory is high. It was found that test-retest reliability coefficients range from 0.74 to 0.94 and are high for an interval of 4 weeks (p<0.005). Confirmatory factor analysis has supported three factor structure of the inventory: "view of self", "view of world" and "view of future". The analysis showed that the model has high goodness of fit. Comparison with three self-report measures released that Cognitive Triad Inventory and its subscales have good convergent validity.
CONCLUSION: The Turkish version of the Cognitive Triad Inventory has been found to be a valid and reliable measure that can be used for the university students of Turkey.

Entities:  

Keywords:  The cognitive triad inventory; beck’s depression model; negative cognitive triad; reliability and validity

Year:  2019        PMID: 30911235      PMCID: PMC6427078          DOI: 10.29399/npa.19390

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  14 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  An evaluation of Beck's cognitive theory of depression in adults with intellectual disability.

Authors:  A J Esbensen; B A Benson
Journal:  J Intellect Disabil Res       Date:  2007-01

3.  Cognitive Triad Inventory (CTI): psychometric properties and factor structure of the German translation.

Authors:  Patrick Pössel
Journal:  J Behav Ther Exp Psychiatry       Date:  2008-12-10

4.  How dysfunctional are the dysfunctional attitudes in another culture?

Authors:  N H Sahin; N Sahin
Journal:  Br J Med Psychol       Date:  1992-03

5.  Resilience: enhancing well-being through the positive cognitive triad.

Authors:  Winnie W S Mak; Ivy S W Ng; Celia C Y Wong
Journal:  J Couns Psychol       Date:  2011-10

6.  Randomized trial of a brief depression prevention program: an elusive search for a psychosocial placebo control condition.

Authors:  Eric Stice; Emily Burton; Sarah Kate Bearman; Paul Rohde
Journal:  Behav Res Ther       Date:  2006-09-27

7.  Prevention of depression in subclinically depressed adults: follow-up effects on the 'Coping with Depression' course.

Authors:  E Allart-van Dam; C M H Hosman; C A L Hoogduin; C P D R Schaap
Journal:  J Affect Disord       Date:  2006-07-24       Impact factor: 4.839

8.  Turkish female academician self-esteem and health beliefs for breast cancer screening.

Authors:  Ilknur Aydin Avci; Hatice Kumcagiz; Busra Altinel; Ayse Caloglu
Journal:  Asian Pac J Cancer Prev       Date:  2014

9.  Global burden of depressive disorders in the year 2000.

Authors:  T B Ustün; J L Ayuso-Mateos; S Chatterji; C Mathers; C J L Murray
Journal:  Br J Psychiatry       Date:  2004-05       Impact factor: 9.319

10.  Internalizing, social competence, and substance initiation: influence of gender moderation and a preventive intervention.

Authors:  Catherine J Lillehoj; Linda Trudeau; Richard Spoth; K A S Wickrama
Journal:  Subst Use Misuse       Date:  2004-05       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.